Download PDF
Thromb Haemost 1975; 33(01): 097-101
DOI: 10.1055/s-0038-1647817
Meeting of the International Committee on Thrombosis and Haemostasis — Symposium on Heparin, Basel, Switzerland, September, 1974
Schattauer GmbH

Conventional Uses of Heparin[*]

George P McNicol
1   University Department of Medicine, The General Infirmary, Leeds LS1. 3EX, England
› Author Affiliations
Further Information

Publication History

Publication Date:
02 July 2018 (online)

    Permissions and Reprints

 

* Presented at the Symposium on Heparin, Basel, Switzerland, September, 1974.


 

  • References

  • 1 Barritt D. W, Jordan S. C. Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial. Lancet 1966; 1: 1309
    PubMedGoogle Scholar
  • 2 Gifford R. H, Feinstein A. R. A critique of methodology in studies of anticoagulant therapy for acute myocardial infarction. New England Journal of Medicine 1969; 280: 351
    CrossrefPubMedGoogle Scholar
  • 3 Gurewich V. Streptokinase in pulmonary embolism: objectives and pathophysiologic considerations in pulmonary thrombo-embolism. Moser K. M, Stein M. (Eds.). Year Book Medical Publishers; Chicago.: p. 296 1973
    Google Scholar
  • 4 Gurewich V, Thomas D. P. Pathogenesis of venous thrombosis in relation to its prevention by dextran and heparin. Journal of Laboratory and Clinical Medicine 1965; 66: 604
    PubMedGoogle Scholar
  • 5 Hunt P. S, Reeve T. E, Holling r. M. A. “Standard” experimental thrombus : observations on its production, pathology, response to heparin and thrombectomy. Surgery 1966; 59: 812
    PubMedGoogle Scholar
  • 6 Kakkar V. V, Flanc C, Home C. T, O’Shea M, Flute P. T. Treatment of deep vein thrombosis : a trial of heparin, streptokinase and arvin. British Medical Journal 1: 806 1969;
    CrossrefPubMedGoogle Scholar
  • 7 Kernohan R. M, Todd C. Heparin therapy in thrombo-embolic disease. Lancet 1966; 1: 621
    PubMedGoogle Scholar
  • 8 O’Sullivan E. F, Hirsch J. Heparin in the treatment of venous thromboembolic disease: administration, control and results. Medical Journal of Australia 1968; 2: 153
    PubMedGoogle Scholar
  • 9 Richards R. L. Peripheral arterial disease. Livingstone; Edinburgh and London: p 75 1970
    Google Scholar
  • 10 Thomas D. P, Gurewich V, Ashford T. P. Platelet adherence to thromboemboli in relation to the pathogenesis and treatment of pulmonary embolism. New England Journal of Medicine 1966; 274: 953
    CrossrefPubMedGoogle Scholar
  • 11 Thomas D. P, Stein M, Tanabe G, Rege V, Wessler S. Mechanism of bronchoconstriction produced by thromboemboli in dogs. American Journal of Physiology 1964; 206: 1207
    PubMedGoogle Scholar
  • 12 Tibbutt D. A, Davies J. A, Anderson J. A, Fletcher E. W. L, Hamill J, Holt J. M, Thomas M. L, Lee G. J, Miller G. A. H, Sharp A. A, Sutton G. C. Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonary embolism. British Medical Journal 1974; 1: 343
    CrossrefPubMedGoogle Scholar
  • 13 Urokinase pulmonary embolism trial study group Urokinase pulmonary embolism trial Phase 1 Results. Journal of the American Medical Association. 1970 214. 2163
    PubMedGoogle Scholar
  • 14 Wessler S, Freiman D. G, Ballon J. D, Katz J. H, Wolff R, Wolf E. Experimental pulmonary embolism with serum-induced thrombi. American Journal of Pathology 1961; 38: 89
    PubMedGoogle Scholar
  • 15 Wessler S, Morris L. E. Studies in intravascular coagulation IV. The effect of heparin and dicoumarol on serum-induced venous thrombosis. Circulation 1955; 12: 553
    CrossrefPubMedGoogle Scholar